Stock LPATH, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Lpath, Inc. Nasdaq

Equities

US5489103060

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Lpath, Inc.
2023 Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index CI
2023 Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
APOLLO ENDOSURGERY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, (form 8-K)
AQ
APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Apollo Endosurgery : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
APOLLO ENDOSURGERY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
APOLLO ENDOSURGERY, INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
Apollo Endosurgery : Merger Agreement - Form 8-K
PU
APOLLO ENDOSURGERY, INC. : Other Events (form 8-K)
AQ
Apollo Endosurgery To Be Acquired By Boston Scientific
AQ
APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN
BU
APOLLO ENDOSURGERY, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Apollo Endosurgery : THIRD AMENDMENT TO OFFICE LEASE AGREEMENT - Form 8-K
PU
APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Apollo Endosurgery : Reports Record Global Revenue in Second Quarter 2022 - Form 8-K
PU
APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Apollo Endosurgery : FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG™ and Apollo REVISE™, New Endoscopic Systems for Patients with Obesity - Form 8-K
PU
APOLLO ENDOSURGERY, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Apollo Endosurgery : Sharon O’Keefe Joins Apollo Endosurgery Board of Directors - Form 8-K
PU
APOLLO ENDOSURGERY, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APEN Stock
  4. Stock
  5. News Lpath, Inc.
  6. Press Releases